X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Procter & Gamble Health with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs TEVA PHARMA (Israel) - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PROCTER & GAMBLE HEALTH   TEVA PHARMA
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-17
TEVA PHARMA
Dec-13
PROCTER & GAMBLE HEALTH/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,3582,873-   
Low Rs9332,495-   
Sales per share (Unadj.) Rs665.01,648.6-  
Earnings per share (Unadj.) Rs56.6103.0-  
Cash flow per share (Unadj.) Rs72.5236.2-  
Dividends per share (Unadj.) Rs15.0090.15-  
Dividend yield (eoy) %1.33.4 39.0%  
Book value per share (Unadj.) Rs441.71,831.3-  
Shares outstanding (eoy) m16.60848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.71.6 105.8%   
Avg P/E ratio x20.226.1 77.7%  
P/CF ratio (eoy) x15.811.4 139.1%  
Price / Book Value ratio x2.61.5 176.9%  
Dividend payout %26.587.5 30.3%   
Avg Mkt Cap Rs m19,0112,276,015 0.8%   
No. of employees `0001.544.9 3.4%   
Total wages/salary Rs m1,6960-   
Avg. sales/employee Rs Th7,150.031,104.9 23.0%   
Avg. wages/employee Rs Th1,098.70-   
Avg. net profit/employee Rs Th608.21,943.1 31.3%   
INCOME DATA
Net Sales Rs m11,0401,398,009 0.8%  
Other income Rs m2400-   
Total revenues Rs m11,2791,398,009 0.8%   
Gross profit Rs m1,376382,846 0.4%  
Depreciation Rs m264113,002 0.2%   
Interest Rs m027,459 0.0%   
Profit before tax Rs m1,352242,384 0.6%   
Minority Interest Rs m01,101 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m170-159,112 -0.1%   
Tax Rs m583-2,959 -19.7%   
Profit after tax Rs m93987,333 1.1%  
Gross profit margin %12.527.4 45.5%  
Effective tax rate %43.1-1.2 -3,531.0%   
Net profit margin %8.56.2 136.2%  
BALANCE SHEET DATA
Current assets Rs m7,523944,210 0.8%   
Current liabilities Rs m2,253823,431 0.3%   
Net working cap to sales %47.78.6 552.6%  
Current ratio x3.31.1 291.3%  
Inventory Days Days5291 57.4%  
Debtors Days Days4196 42.3%  
Net fixed assets Rs m1,240456,621 0.3%   
Share capital Rs m1663,441 4.8%   
"Free" reserves Rs m7,1670-   
Net worth Rs m7,3331,552,923 0.5%   
Long term debt Rs m0714,833 0.0%   
Total assets Rs m9,9123,194,900 0.3%  
Interest coverage xNM9.8-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.10.4 254.5%   
Return on assets %9.53.6 263.7%  
Return on equity %12.85.6 227.7%  
Return on capital %20.84.9 420.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-2,0280-   
CASH FLOW
From Operations Rs m537222,770 0.2%  
From Investments Rs m-476-78,937 0.6%  
From Financial Activity Rs m-220-267,228 0.1%  
Net Cashflow Rs m-160-123,394 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.82 Rs / USD

Compare PROCTER & GAMBLE HEALTH With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES  ALEMBIC LTD  TTK HEALTHCARE  CADILA HEALTHCARE  GSK PHARMA  



Today's Market

Yes Bank's Road Ahead(Podcast)

The stock markets witnessed selling pressure in the week gone by. Market participants remained cautious tracking tepid quarterly earnings amid weak cues.

Related Views On News

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

MERCK LTD Announces Quarterly Results (3QFY19); Net Profit Up 31.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, MERCK LTD has posted a net profit of Rs 135 m (up 31.3% YoY). Sales on the other hand came in at Rs 2 bn (down 32.8% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound (Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Here's What to Do with Falling Small Cap Stocks (Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock (The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Jul 19, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH 8-QTR ANALYSIS

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS